| |
|
|
|
Kazia Therapeutics Limited  
|
|
2.3251 -0.055 (-0.02%) |
08-19 11:17 |
|
Open: |
2.3251 |
Pre close: |
2.38 |
Target:
|
3.12
|
|
High: |
2.3251 |
Low: |
2.3251 |
Resistance:
|
2.67
2.90
|
|
Volume: |
595 |
Market Cap: |
14M |
Support:
|
2.31
1.92
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.39
 |
MACD |
MACD(12,26):
|
-0.09 |
|
MA(20): |
2.53 |
Signal(12,26,9): |
-0.08 |
|
MA(100): |
2.93 |
Stochastic Oscillator |
%K(14,3):
|
8.96 |
|
MA(250): |
3.00 |
%D(3): |
13.27 |
|
Average Volume(K) |
3-Month: |
253
|
52-Week |
High:
|
4.27 |
|
10-Days: |
159 |
Low: |
2.04 |
|
RSI |
RSI(14):
|
35.74 |
Change(%): |
-36.1 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.920 |
Return on Equity (ttm) |
-56.6 |
Shares Out. (M) |
6.22 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-19.1 |
Shares Float (M) |
3.90 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
-47.0 |
% Held by Institutions |
1.92 |
|
Forward EPS |
1.#IO |
Gross Profit (p.s.) |
0.482 |
Shares Short (K) |
2 |
|
Book Value (p.s.) |
2.940 |
EBITDA (p.s.) |
0.000 |
P/E |
-2.53 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.79 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
0.00 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
0.00 |
P/CF |
0.00 |
|
|
|
|
|
|
